Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

More than a pain in the neck: how discussing chronic pain affects hypertension medication intensification.

Krein SL, Hofer TP, Holleman R, Piette JD, Klamerus ML, Kerr EA.

J Gen Intern Med. 2009 Aug;24(8):911-6. doi: 10.1007/s11606-009-1020-y. Epub 2009 May 29.

2.

Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension.

Bolen SD, Samuels TA, Yeh HC, Marinopoulos SS, McGuire M, Abuid M, Brancati FL.

J Gen Intern Med. 2008 May;23(5):543-50. doi: 10.1007/s11606-008-0507-2. Epub 2008 Jan 25.

3.

When more is not better: treatment intensification among hypertensive patients with poor medication adherence.

Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA.

Circulation. 2008 Jun 3;117(22):2884-92. doi: 10.1161/CIRCULATIONAHA.107.724104. Epub 2008 May 27.

4.
5.

The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure.

Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP.

Ann Intern Med. 2008 May 20;148(10):717-27.

PMID:
18490685
6.

Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.

Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, Singh RF, Wood Y, Kaplan RM, Mangione CM.

Clin Ther. 2014 Sep 1;36(9):1244-54. doi: 10.1016/j.clinthera.2014.06.030. Epub 2014 Jul 30.

7.

A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures.

Vigen R, Shetterly S, Magid DJ, O'Connor PJ, Margolis KL, Schmittdiel J, Ho PM.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):276-82. doi: 10.1161/CIRCOUTCOMES.112.965665. Epub 2012 May 10.

8.

Effect of unrelated comorbid conditions on hypertension management.

Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS.

Ann Intern Med. 2008 Apr 15;148(8):578-86.

PMID:
18413619
9.

Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model.

Fontil V, Bibbins-Domingo K, Kazi DS, Sidney S, Coxson PG, Khanna R, Victor RG, Pletcher MJ.

J Gen Intern Med. 2015 Aug;30(8):1147-55. doi: 10.1007/s11606-015-3231-8. Epub 2015 Mar 7.

10.

The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.

Daugherty SL, Powers JD, Magid DJ, Masoudi FA, Margolis KL, O'Connor PJ, Schmittdiel JA, Ho PM.

Hypertension. 2012 Aug;60(2):303-9. doi: 10.1161/HYPERTENSIONAHA.112.192096. Epub 2012 Jun 25.

11.

Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.

Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS.

Arch Intern Med. 2008 Feb 11;168(3):271-6. doi: 10.1001/archinternmed.2007.72.

PMID:
18268167
12.

A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?

Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, O'Connor PJ, Pawloski PA, Sperl-Hillen JM, Trower NK, Tucker AD, Green BB.

J Gen Intern Med. 2015 Nov;30(11):1665-72. doi: 10.1007/s11606-015-3355-x.

13.

Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study.

Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M.

J Hypertens. 2004 Jun;22(6):1221-9.

PMID:
15167458
14.

Patient-provider concordance in the prioritization of health conditions among hypertensive diabetes patients.

Zulman DM, Kerr EA, Hofer TP, Heisler M, Zikmund-Fisher BJ.

J Gen Intern Med. 2010 May;25(5):408-14. doi: 10.1007/s11606-009-1232-1. Epub 2010 Feb 2.

15.

Treatment Intensification for Hypertension in US Ambulatory Medical Care.

Mu L, Mukamal KJ.

J Am Heart Assoc. 2016 Oct 22;5(10). pii: e004188.

16.

Understanding racial disparities in treatment intensification for hypertension management.

Manze M, Rose AJ, Orner MB, Berlowitz DR, Kressin NR.

J Gen Intern Med. 2010 Aug;25(8):819-25. doi: 10.1007/s11606-010-1342-9. Epub 2010 Apr 13.

17.

Resistant hypertension revisited: a comparison of two university-based cohorts.

Garg JP, Elliott WJ, Folker A, Izhar M, Black HR; RUSH University Hypertension Service.

Am J Hypertens. 2005 May;18(5 Pt 1):619-26.

PMID:
15882544
18.

Treatment decisions for complex patients: differences between primary care physicians and midlevel providers.

Subramanian U, Kerr EA, Klamerus ML, Zikmund-Fisher BJ, Holleman RG, Hofer TP.

Am J Manag Care. 2009 Jun;15(6):373-80.

19.
20.

Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program.

Klamerus ML, Kerr EA, Bosworth HB, Schmittdiel JA, Heisler M.

Chronic Illn. 2014 Mar;10(1):60-73. doi: 10.1177/1742395313496590. Epub 2013 Jul 26.

Supplemental Content

Support Center